Which manufacturer savings or direct-pay options may apply to Wegovy?

Novo Nordisk, the manufacturer of Wegovy, offers a Savings Card that may reduce out-of-pocket costs for eligible patients with commercial insurance.

What is the Wegovy Savings Card?

The Wegovy Savings Card is a copay assistance program offered by its manufacturer, Novo Nordisk. It is designed to lower the amount a patient pays for their prescription at the pharmacy. This program is intended for brand-name Wegovy dispensed by a retail pharmacy and is not a form of health insurance.

For patients with commercial insurance that covers Wegovy, the savings card can be significant. Eligible individuals may pay as little as $0 for a 28-day supply, with the card providing a maximum savings of $225 per month. The actual savings depend on the patient's insurance plan and copay amount.

If a patient's commercial insurance does not cover Wegovy, the savings card may still provide a benefit, offering a maximum savings of $500 per 28-day supply. However, given Wegovy's list price of over $1,300, the remaining out-of-pocket cost can still be substantial.

The program has specific terms and conditions, including monthly and annual savings limits. Patients can apply for the card and find detailed eligibility requirements on the official Wegovy website provided by Novo Nordisk.

Who is Eligible for the Wegovy Savings Program?

The primary eligibility requirement for the Wegovy Savings Card is having an active commercial or private insurance plan. This includes most employer-sponsored or individually purchased health plans. The program is available for U.S. residents.

Crucially, the program is not available to patients whose prescriptions are paid for in whole or in part by any state or federally funded healthcare program. This exclusion includes Medicare, Medicaid, TRICARE, VA, Department of Defense, or any similar state or federal program.

This restriction is in place due to federal anti-kickback statutes, which limit the use of manufacturer coupons and copay cards for beneficiaries of government health programs. The Office of Inspector General for the U.S. Department of Health and Human Services has clarified that such offers can be problematic.

The savings offer is valid for the FDA-approved indications for Wegovy, which includes adults and pediatric patients aged 12 years and older with obesity or overweight with at least one weight-related comorbidity.

What are the Options for Patients on Government Insurance?

Patients with Medicare Part D, Medicaid, or other government-funded insurance cannot use the Wegovy Savings Card. Their coverage options for weight management medications are determined by their specific plan.

Historically, Medicare Part D has been prohibited by law from covering drugs used for weight loss. However, with the FDA's approval of Wegovy for reducing major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight, some Part D plans may begin to cover it for this specific indication.

Medicaid coverage for anti-obesity medications varies widely by state. Patients should consult their state's Medicaid Preferred Drug List (PDL) or contact their plan administrator to determine if Wegovy is a covered benefit. A prior authorization is often required.

For those on government plans without coverage, the primary option may be to appeal the decision or seek an exception, though this is not always successful. The Novo Nordisk Patient Assistance Program (PAP) is another avenue for qualifying low-income, uninsured individuals, but it has strict income requirements and is separate from the savings card.

Exploring Physician-Supervised Weight Loss Programs

When brand-name medications like Wegovy are unaffordable or not covered by insurance, a comprehensive, physician-supervised [weight loss](/weight-loss) program can provide alternative pathways to care. These programs focus on a holistic approach to health.

A physician-led program evaluates your complete health profile to determine the most appropriate treatment plan. If medication is deemed clinically appropriate, your physician can prescribe treatments tailored to your needs and circumstances.

GOAL.MD's medical team provides ongoing supervision and prescribes medications, including GLP-1s, that are sourced from licensed U.S. pharmacies. This ensures patients receive care that is both clinically sound and accessible.

These programs integrate medication management with personalized coaching on nutrition, fitness, and behavior change, addressing the multiple factors that contribute to sustainable weight management.

Bottom Line

The Wegovy Savings Card from Novo Nordisk can substantially lower costs for patients with commercial insurance, potentially reducing copays to as little as $0. However, it cannot be used by individuals with Medicare, Medicaid, or other government insurance.

Even with a savings card, patients whose insurance does not cover Wegovy at all will face a significant out-of-pocket expense. The list price remains high, and the card only provides a partial discount in these cases.

Patients facing access or affordability challenges with brand-name medications should discuss all available options with a healthcare provider. This may include exploring comprehensive, physician-supervised programs that offer alternative treatment plans.

This information is for educational purposes only and does not constitute medical advice. Please consult a healthcare professional for medical advice.

Drafted by the GOAL.MD Authority Engine and approved editorially by GOAL.MD staff. This page has not received its own physician review. Physician-supervised telehealth. More at goal.md/answers.